Current treatment strategies and recommendations in psoriatic arthritis
Int J Rheum Dis
.
2023 Jan;26(1):8-10.
doi: 10.1111/1756-185X.14474.
Authors
Pei-En Kao
1
,
Yung-Heng Lee
2
3
4
5
,
Kevin Sheng-Kai Ma
6
7
8
,
Amy Ker
1
,
Ying-Ying Leung
9
10
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
3
Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung, Taiwan.
4
Department of Senior Services Industry Management, Minghsin University of Science and Technology, Hsinchu, Taiwan.
5
Department of Recreation and Sport Management, Shu-Te University, Kaohsiung, Taiwan.
6
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
7
Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
8
Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taipei, Taiwan.
9
Department of Rheumatology and Immunology, Singapore General Hospital, Singapore City, Singapore.
10
Duke-NUS Medical School, Singapore City, Singapore.
PMID:
36591904
DOI:
10.1111/1756-185X.14474
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Psoriatic* / diagnosis
Arthritis, Psoriatic* / drug therapy
Arthritis, Rheumatoid* / drug therapy
Humans
Substances
Antirheumatic Agents